Skip to the content
logo mainlogo darklogo light
  • About Us
  • Our products
    • Proprietary Curative Molecules
    • RNA Modifying Molecules
    • Our Services on demand
  • Our Team
  • Publications
  • SA&SP
  • Careers
  • News&Blog
  • Contact Us
logo main
  • About Us
  • Our products
    • Proprietary Curative Molecules
    • RNA Modifying Molecules
    • Our Services on demand
  • Our Team
  • Publications
  • SA&SP
  • Careers
  • News&Blog
  • Contact Us
News

CERNAIS Presents Innovative RNA-Based Therapeutic Strategies at the 2025 LouLou Foundation Meeting

Andrea
Ottobre 31, 2025
News

CERNAIS Among the Finalists of StartUp Breeze 2025

Andrea
Ottobre 24, 2025
News

CERNAIS Showcases Innovative RNA-Based Therapeutics at MoML 2025 @ MIT

Andrea
Ottobre 24, 2025
News

Drug Repurposing: A Fast-Track Solution for Rare Diseases – towards a cure for Rett syndrome

Andrea
Aprile 3, 2025
Blog

Exploring Advances in Rett Syndrome Treatments

Andrea
Febbraio 19, 2025
Blog

Olivetti: The Italian Father of Home Computers

Andrea
Gennaio 10, 2025
News

CERNAIS competes at the National competition for the best new biotech in 2024.

Andrea
Dicembre 13, 2024
News

CERNAIS starts a collaboration with Uncommon Therapeutics for the development of a new combo treatment for Rett syndrome 

Andrea
Dicembre 1, 2024
News

CERNAIS wins the “Best Tuscany Start-Up 2024” competition.

Andrea
Ottobre 14, 2024
Blog

Carolina’s smile

Andrea
Agosto 2, 2024

Navigazione articoli

1 2

Subscribe for updates

    I accept the terms of the privacy policy of this site.

    About Us

      Our Products

      • Proprietary Curative Molecules
      • RNA Modifying Molecules
      • Our Services

        • Full Strategic Screening
        • Molecule Sub-Screening

    Our Team

      Publications

        SAB

    Careers

      News

        Contact Us

    © 2024 Cernais AI-Powered Drug Discovery & RNA Therapeutics | All Rights Reserved | Privacy Policy

    Back to top Drag
    w